3,361
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence of frailty among community-dwelling elderly persons in Spain and factors associated with it

, , , , , , , & show all
Pages 190-196 | Received 08 Mar 2018, Accepted 17 Jun 2019, Published online: 22 Oct 2019

Abstract

Background: For effective prevention and intervention, and reduction of dependency, it is essential to determine the presence of frailty in the community.

Objectives: To describe the prevalence of frailty among elderly persons living independently, in two primary healthcare areas in Spain; to identify factors correlated with its presence.

Methods: This descriptive cross-sectional study was conducted between May 2015 and July 2016 among non-institutionalized individuals aged ≥70 years living in the primary healthcare areas of Gipuzkoa and Costa del Sol (Spain). The main outcome variable was the prevalence of frailty (determined by modified Fried criteria). The independent study variables were sociodemographic characteristics, anthropometric data and health-related life habits.

Results: The study population consisted of 855 individuals (53% women). The overall prevalence of frailty was 26.2% (Gipuzkoa 14.2%, Costa del Sol 38.0%). Using multiple logistic regression, the following factors were associated with frailty: female sex (OR: 1.98; 95%CI: 1.37–2.86); cumulative illness rating scale (OR: 1.05; 95%CI: 1.00–1.10); self-perceived health status (OR: 0.96; 95%CI: 0.95–0.97); self-perceived unhealthy lifestyle (OR: 3.37; 95%CI: 2.05–8.87); dissatisfaction with the domestic environment (OR: 2.11; 95%CI: 1.18–3.76); and cognitive impairment (OR: 4.10; 95%CI: 2.05–8.19). In the multivariable model, ‘geographical area’ differences persisted, with an OR of 3.51 (95%CI: 2.29–5.36) for the Costa del Sol area, using Gipuzkoa as reference.

Conclusion: In this population of community-dwelling persons aged 70 years and over, the prevalence of frailty was 26%. Factors correlated with frailty were female sex, comorbidity, poorer self-perceived lifestyle and health status, and dissatisfaction with the domestic environment.

This article is part of the following collections:
The EJGP Collection on Multimorbidity

KEY MESSAGES

  • In this sample of men and women, aged ≥70 years and living independently in the community, the prevalence of frailty was 26%

  • There were significant differences between both studied geographical areas

  • Women presented frailty twice as often as men

Introduction

Among the physiological changes of aging, frailty is a multidimensional clinical condition characterized by a progressive decrease in reserve capacity and adaptability, which is reflected in a global deterioration of health when exposed to a stressor [Citation1]. The vulnerability of a frail elderly person is a dynamic condition that heightens the risk of adverse events such as falls, hospitalization, inability to perform basic life activities and premature mortality [Citation2]. Among definitions of frailty is the phenotype proposed by Fried et al., widely used in research, based on the presence of low gait speed, reduced grip strength, decreased activity level, fatigue and unintentional weight loss [Citation3].

The prevalence of frailty in the community varies greatly. In recent years, values ranging from 4 to 59% have been reported, both in developed countries (such as Spain) and in less developed ones [Citation4–7]. In all countries, overall levels of frailty are higher among women, and there is an inverse relationship between frailty and education, and between frailty and economic level. However, differences have been observed according to the health system available and the social support received.

Community identification of frailty is essential to ensure effective preventive interventions for age-related conditions, and consequently to prevent dependency [Citation8]. This question is granted high priority in health authority agendas [Citation9].

This study compares the prevalence of frailty in two primary healthcare (PHC) areas (the organizational structure for the administration and provision of PHC in Spain), located within the same country (Spain), but in different geographical areas (north vs south).

The main purpose of this study is to describe the prevalence of frailty among elderly persons living independently, in two PHC areas in Spain, and then to identify sociodemographic characteristics, anthropometric data and health-related life habits.

Methods

Study design

This descriptive cross-sectional study was conducted from May 2015 to July 2016, addressing a multicentre prospective cohort with two years of follow-up, according to a previously described method [Citation10]. The study was conducted in two PHC areas in Gipuzkoa and western Costa del Sol (northern and southern Spain, respectively). The characteristics of these PHC areas are summarized in . The research unit located in each area designed, coordinated and implemented the study.

Table 1. Descriptive analysis of the study population.

Setting and study population

The following inclusion criteria were applied: all participants should live within the community, be functionally independent (Barthel’s Index > 90 points), be aged 70 years or more and provide signed informed consent (Supplementary Appendix A). Persons who were terminally ill, or who spent less than six months per year in their residence or who had difficulty in communicating fluently in Spanish were excluded.

Potential participants were selected randomly from the administrative databases of the participating PHC (using the census of individuals registered to receive PHC, not the general population census) according to criteria of representativeness by age and sex. All subjects thus selected were contacted by letter and by phone and given information on the project. Those who expressed interest in taking part took the Barthel test by phone, and those whose test result was less than or equal to 90 were excluded.

In each PHC area, a trained nurse, the same person in every case, made the baseline assessment of the study subjects, via a face-to-face interview in which the dependent and independent variables were assessed.

Variables

Dependent variable: frailty. The main outcome variable was the presence of frailty, assessed according to a modified version of the following criteria proposed by Fried:

  1. Unintentional weight loss (over 4.5 kg) in the last year.

  2. Low level of physical activity, identified if the person presented one of the following conditions: (a) walk less than 30 min continuously every day, three times a week; (b) do less than 20 min of sports activity, once a week; (c) have difficulty carrying the daily shopping.

  3. Fatigue or lack of energy, measured by an affirmative response to either of these items on the CES-D Scale: ‘I felt that everything I did was an effort;’ ‘I could not get going’ [Citation11].

  4. Muscle weakness, identified according to the test, ‘Get up from a chair and sit down again, five times, as fast as possible’ [Citation12]. If this task took 12 s or more, the criterion was considered to be met.

  5. Slowness in mobility, measured using the timed get up and go test [Citation13]. If this task took 10 s or more, the criterion was considered to be met.

Participants were identified as frail if they presented three or more of the above criteria, and were otherwise robust.

Independent variables. The independent study variables were sociodemographic characteristics, anthropometric data and health-related lifestyle. categorizes the study variables considered. Self-perceived health status was evaluated with the EQ-5D-3L visual analogue scale (VAS; 0 (worst) – 100 (best)). Cognitive status was assessed using the mini-mental status examination (MMSE) scale (0–30 points; normal: 27–30; slight deficit: 23–26; cognitive impairment: <23). Comorbidity was assessed using the cumulative illness rating scale, CIRS; 0 (absence)–56 points (worse comorbidity status). Finally, the number of daily medicinal drugs was recorded.

Table 2. Descriptive analysis of the study population, total and segmented by geographical area.

Sample size estimation

The sample size required for our analysis was calculated to assess the predictive capacity of frailty instruments for adverse events, as part of a subsequent cohort study [Citation10]. This calculation showed that a minimum sample size of 650 subjects (total for the two cohorts) was needed. This minimum requirement was then exceeded by 40% to allow for possible losses to follow-up, resulting in a final requirement of 450 subjects per study group.

Statistical analysis

The data were entered into a Microsoft Access database (Version 2013) and analysed using SPSS for Windows, Version 16.0. (SPSS Inc., Chicago, IL, USA). The continuous variables are presented with means and standard deviations (SD), and categorical ones by frequencies and percentages (%). Differences between the groups were evaluated using Student’s t-test for continuous variables (Mann–Whitney U test for non-normal distributions), and the chi-squared test for categorical ones (Fisher’s exact test for expected frequencies <5).

Logistic regression analyses were performed, in bivariate and multivariate fashion, taking the presence of frailty as the outcome variable, and determining the odds ratios (OR) with 95% confidence intervals (95%CI) of the independent variables. In the multiple logistic regression analysis ‘geographical area’ was used as the first step, and in a second stepwise block (both forward and backward to obtain a more parsimonious model), the independent variables found to be statistically significant in the prior bivariate analysis were introduced, conditioned by selecting the model with the fewest variables and strongest goodness of fit. For the categorical variables, a value of 1 was assigned to the reference category. Goodness of fit was assessed using the Hosmer–Lemeshow test, and the variance of the model was explained by Nagelkerke’s R2. In all analyses, the level of statistical significance was set at P <0.05.

Research ethics

The project was approved by the corresponding research ethics committees (CEIC Euskadi 01/2015 and CEI Costa del Sol 11/2014). The data was registered anonymously, in strict accordance with applicable data protection laws and regulations. This study was supported by public grants from Instituto de Salud Carlos III and co-funded by the European Regional Development Fund.

Results

Participants

Of the 885 individuals initially included, 20 did not meet the age and Barthel criteria and they were excluded. In another 10 patients, the frailty identification criteria could not be assessed. Thus, the final study sample consisted of 855 subjects, 432 (50.5%) from the Costa del Sol and 423 (49.5%) from Gipuzkoa. The participants’ characteristics are summarized in .

Prevalence of frailty and population characteristics

Frailty prevalence in the total sample was 26.2% (95%CI: 23.2–29.2). In Gipuzkoa, the prevalence was 14.2% (95%CI: 10.7–17.6), and in Costa del Sol it was 38% (95%CI: 33.3–42.7). The participants’ sociodemographic characteristics, lifestyle habits and health status are summarized in , both for the total population and for each study area.

Frailty-related factors

The results for the frailty-related factors, according to bivariate and multiple logistic regression, are shown in . In addition to the above differences between the study areas (raw OR: 3.7, 95%CI: 2.65–5.18), differences were also observed between the sexes, with women being more likely to present frailty (OR: 2.08, 95%CI: 1.51–2.86).

Table 3. Simple and logistic regression according to the presence of frailty.

The multivariate model was obtained by step-forward methods with a sample of 801 individuals (the variables included in the model were shown to be identical by replicating the analysis using the step-backward method). The goodness of fit was acceptable (P = 0.665) and the level of explained variance was 0.519. The geographical area was included in the model, with an adjusted OR of 3.51 (95%CI: 2.29–5.36) for the Costa del Sol area to Gipuzkoa. Sex differences were also included; thus, women were at greater risk of frailty, with an adjusted OR of 1.98 (95%CI: 1.37–2.86). Increased frailty prevalence was also related to the CIRS index of comorbidity (OR: 1.05; 95%CI: 1.00–1.10; which means an increase in risk of 5% for each unit on the scale), whereas self-perceived functional health status was a protective factor (OR: 0.96; 95%CI: 0.95–0.97; in terms of risk, an increase of 4% for each point less on the scale). The presence of frailty was higher among those who perceived their health to be poor (OR: 3.37; 95%CI: 2.05–5.54), those who were dissatisfied with their domestic environment (OR: 2.11; 95%CI: 1.18–3.76) and those who had an inadequate cognitive status, regarding both full cognitive impairment (OR: 4.1; 95%CI: 2.05–8.19) and slight cognitive deficit (OR: 2.07; 95%CI: 1.18–3.76).

Discussion

Main findings

The analyses revealed a prevalence of frailty (26.2%) in this sample of individuals aged 70 years and over living independently in the community. Frailty presence was higher among women, those who perceived their lifestyles to be unhealthy, those unsatisfied with their domestic environment, and those with an impaired cognitive status. The prevalence of frailty was three times as high among participants living in the southern PHC area (Costa del Sol) than in the northern one (Gipuzkoa).

Limitations

A limitation of the present study is that the weakness criterion of the Fried phenotype was measured by the timed get up and go test, and not with a dynamometer adjusting the values according to BMI and sex. However, the Fried criteria are frequently implemented with modified items [Citation14,Citation15].

Results in relation to existing literature

Geographical differences. The prevalence of frailty (26.2%) in this population of people over 70 is practically the median of the prevalence range identified in a recent systematic review (4–59.1) [Citation4]. Focusing on comparisons with each PHC area, studies, which have evaluated frailty using Fried’s modified phenotype, have found prevalence rates similar to those in Gipuzkoa (14%). Thus, the FRALLE survey reported a prevalence of 10% in Lleida (North East Spain) [Citation16]; another study reported 11% in urban areas to the north of Madrid [Citation14], and the FRADEA study reported 17% in Albacete [Citation15]. Similar studies have been carried out in developed regions in other European countries, for example, the Bordeaux three-city study (reported prevalence of frailty: 18%) conducted in southern France [Citation17]. In the Costa del Sol area, the prevalence of frailty according to the modified Fried phenotype (38%) is higher than that reported in previous studies conducted in developed European countries using a comparable methodology; however, similar results have been reported in Latin America, such as the 39% obtained in a study carried out in a Mexican population living in urban areas [Citation18], and the value of 37% reported in the SABE macro study carried out in cities in Latin America and the Caribbean [Citation19].

At an ecological level, the differences between the two study areas may be due to our evaluation of areas presenting different socioeconomic levels. As Campbell and Buchner pointed out, frailty is a multi-systemic syndrome in which the interaction between individuals and their environment is a key factor [Citation20]. Thus, a possible explanation in ecological terms is that Gipuzkoa forms part of the Basque Country in northern Spain, which is one of the most highly developed areas in the EU, by GDP per capita, whilst the Costa del Sol in Andalusia (southern Spain), is classed as a transition region; the resulting differences in social and health spending may affect levels of frailty within the population. An ecological study in several European countries recorded a strong correlation between a country’s economic indicators and its level of frailty [Citation21].

Individual differences. Regarding the individual, there were gender-specific differences, with women being twice as likely as men to present frailty; this finding is consistent with previous studies [Citation4,Citation6].

Our finding of an inverse relationship between frailty and perceived quality of life is in line with a previous meta-analysis [Citation22], which included studies with a comparable design and level of statistical power [Citation23,Citation24]. Also relevant to our multivariate analysis is the positive relationship reported in previous research between frailty and cognitive impairment and between frailty and multimorbidity [Citation25,Citation26].

Although smoking is not significantly associated with frailty, smokers and ex-smokers tend to present less frailty than non-smokers (20% and 30%, respectively), values that are similar to those reported in a prevalence study of similar design conducted in Mexico [Citation27]. This pattern might be explained by the presence of Neyman bias [Citation28], which affects research designs in which prevalent cases are evaluated.

Although age is the most frequently correlated sociodemographic characteristic, in a positive sense, with frailty [Citation29], this relationship was not detected in our 70+ sample.

Implications

The considerable difference observed in the presence of frailty between the two study areas, according to individual-related variables, highlights the existence of geographical inequalities; therefore, action should be taken by public health authorities to promote screening and healthcare interventions.

Conclusion

A high prevalence of frailty was observed in a sample of men and women aged 70 years and over, and living independently in the community. This prevalence was three times as high in a region with a relatively low economic level. Individual factors correlated with frailty were female sex, comorbidity, poorer self-perceived lifestyle and health status, and dissatisfaction with the domestic environment.

Authors’ contributions

IV and FRR conceived the study, designed the study protocol, sought funding and ethical approval and wrote the manuscript; AD, MPR and YMB participated in data collection; FRR, MM and KV analysed and interpreted the data; FRR drafted the report; all authors critically reviewed the report. All authors have seen and approved the final, submitted version of this manuscript.

GIFEA group: Euskadi: Itziar Vergara, Mónica Machón, Kalliopi Vrotsou, Ana Isabel Díez, Maider Mateo-Abad, Bakarne Aguirre, Izaskun Moreda, Olatz Miranda, Leonor Rico, Irati Rodriguez, Antonio Bueno, Jazmina Nuñez, Manel Ferrán, Arantza Calvo, Carolina Güell.

Andalusia: Francisco Rivas-Ruiz, Raúl Quirós López, Teresa Téllez Santana, María Padilla-Ruiz (Agencia Sanitaria Costa del Sol); Eugenio Contreras-Fernández, Yolanda de Mesa Berenguer, Alonso Montiel Luque, María A Nava Del Val, María C Saucedo-Figueredo (Distrito de Atención Primaria Costa del Sol); María J Vázquez Blanco (Facultad de Ciencias de la Salud. Universidad de Málaga).

Supplemental material

Supplementary Material: Barthel Index Activity

Download MS Word (13.1 KB)

Acknowledgements

The authors thank all the health centre patients who gave us their time and patience to complete the questionnaires involved in this study. The authors also thank the directors of each of the participating health centres for allowing us the use of their facilities to conduct this study: in Gipuzcoa – Centro de Salud Errenteria-Beraun, Centro de Salud Hondarribia and Centro Salud Ambulatorio Irún Centro; and in Costa del Sol – La Lobilla (Estepona), UGC Las Albarizas (Marbella), UGC Los Boliches (Fuengirola) and UGC San Miguel (Torremolinos).

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Additional information

Funding

This study was supported by grants from Instituto de Salud Carlos III (contract numbers: PI14/01003, PI14/01905 and REDISSEC RD12/0001/0010), and co-funded by Fondo Europeo de Desarrollo Regional – FEDER (contract numbers: RD06/0001/0000 and RD06/0001/1009), ‘Una manera de hacer Europa.’

References

  • Morley JE, Vellas B, van Kan GA. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392–397.
  • Vermeiren S, Vella-Azzopardi R, Beckwee D, et al. Frailty and the prediction of negative health outcomes: a meta-analysis. J Am Med Dir Assoc. 2016;17:1163.e1–e1163.e17.
  • Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156.
  • Collard RM, Boter H, Schoevers RA, et al. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60:1487–1492.
  • Harttgen K, Kowal P, Strulik H, et al. Patterns of frailty in older adults: comparing results from higher and lower income countries using the Survey of Health, Ageing and Retirement in Europe (SHARE) and the Study on Global AGEing and Adult Health (SAGE). PLoS One. 2013;8:e75847.
  • Fernandez-Bolanos M, Otero A, Zunzunegui MV, et al. Sex differences in the prevalence of frailty in a population aged 75 and older in Spain. J Am Geriatr Soc. 2008;56:2370–2371.
  • Santos-Eggimann B, Cuenoud P, Spagnoli J, et al. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci. 2009;64:675–681.
  • Cesari M, Prince M, Thiyagarajan JA, et al. Frailty: an emerging public health priority. J Am Med Dir Assoc. 2016;17:188–192.
  • European Innovation Partnership on Active and Health Ageing. European Commision. Action Group A3. Prevention of functional decline and frailty [Internet]. 2016 [cited 2017 Jan 1]. p. 1–51. Available from: https://ec.europa.eu/eip/ageing/actiongroup/index/a3/key-documents_en.
  • Vergara I, Rivas-Ruiz F, Vrotsou K, et al. Validation and comparison of instruments to identify frail patientes in primary care settings: study protocol. BMC Health Serv Res. 2016;16:354.
  • Radloff LS. The CES-D scale. A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
  • Lusardi MM, Fritz S, Middleton A, et al. Determining risk of falls in community dwelling older adults: a systematic review and meta-analysis using posttest probability. J Geriatr Phys Ther. 2017;40:1–36.
  • Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test. Arch Phys Med Rehabil. 1986;67:387–389.
  • Castell M-V, Sanchez M, Julian R, et al. Frailty prevalence and slow walking speed in persons age 65 and older: implications for primary care. BMC Fam Pract. 2013;14:86.
  • Abizanda P, Romero L, Sánchez-Jurado PM, et al. Frailty and mortality, disability and mobility loss in a Spanish cohort of older adults: the FRADEA study. Maturitas 2013;74:54–60.
  • Jurschik P, Nunin C, Botigue T, et al. Prevalence of frailty and factors associated with frailty in the elderly population of Lleida, Spain: the FRALLE survey. Arch Gerontol Geriatr. 2012;55:625–631.
  • Tabue-Teguo M, Grasset L, Avila-Funes JA, et al. Prevalence and co-occurrence of geriatric syndromes in people aged 75 years and older in France: results from the bordeaux three-city study. J Gerontol A Biol Sci Med Sci. 2018;73:109–116.
  • Pozos-Lopez T, Navarrete-Reyes AP, Avila-Funes JA. Is frailty associated with cardiovascular drug use? J Am Geriatr Soc. 2011;59:1977–1979.
  • Alvarado BE, Zunzunegui M-V, Beland F, et al. Life course social and health conditions linked to frailty in Latin American older men and women. J Gerontol A Biol Sci Med Sci. 2008;63:1399–1406.
  • Campbell AJ, Buchner DM. Unstable disability and the fluctuations of frailty. Age Ageing. 1997;26:315–318.
  • Theou O, Brothers TD, Rockwood MR, et al. Exploring the relationship between national economic indicators and relative fitness and frailty in middle-aged and older Europeans. Age Ageing. 2013;42:614–619.
  • Kojima G, Iliffe S, Jivraj S, et al. Association between frailty and quality of life among community-dwelling older people: a systematic review and meta-analysis. J Epidemiol Community Health. 2016;70:716–721.
  • Masel MC, Graham JE, Reistetter TA, et al. Frailty and health related quality of life in older Mexican Americans. Health Qual Life Outcomes. 2009;7:70.
  • Lin C-C, Li C-I, Chang C-K, et al. Reduced health-related quality of life in elders with frailty: a cross-sectional study of community-dwelling elders in Taiwan. PLoS One. 2011;6:e21841.
  • Godin J, Armstrong JJ, Rockwood K, et al. Dynamics of frailty and cognition after age 50: why it matters that cognitive decline is mostly seen in old age. J Alzheimers Dis. 2017;58:231–242.
  • Boeckxstaens P, Vaes B, Legrand D, et al. The relationship of multimorbidity with disability and frailty in the oldest patients: a cross-sectional analysis of three measures of multimorbidity in the BELFRAIL cohort. Eur J Gen Pract. 2015;21:39–44.
  • Garcia-Pena C, Avila-Funes JA, Dent E, et al. Frailty prevalence and associated factors in the Mexican health and aging study: a comparison of the frailty index and the phenotype. Exp Gerontol. 2016;79:55–60.
  • Rivas-Ruiz F, Pérez-Vicente S, González-Ramírez AR. Bias in clinical epidemiological study designs. Allergol Immunopathol (Madr). 2013;41:54–59.
  • Feng Z, Lugtenberg M, Franse C, et al. Risk factors and protective factors associated with incident or increase of frailty among community-dwelling older adults: a systematic review of longitudinal studies. PLoS One. 2017;12:e0178383.